This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Top Analyst Reports for Booking Holdings, U.S. Bancorp & CME Group
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Booking Holdings Inc. (BKNG), U.S. Bancorp (USB) and CME Group Inc. (CME).
Why Should You Stay Invested in CME Group (CME) Stock Now?
by Zacks Equity Research
CME Group's (CME) global presence, compelling product portfolio, and focus on over-the-counter clearing services and effective capital deployment poise it well for growth.
Are Options Traders Betting on a Big Move in CME Group (CME) Stock?
by Zacks Equity Research
Investors need to pay close attention to CME Group (CME) stock based on the movements in the options market lately.
The Zacks Analyst Blog Highlights Analog Devices, The Southern Company, Canadian Pacific Railway, CME Group and UBS
by Zacks Equity Research
Analog Devices, The Southern Company, Canadian Pacific Railway, CME Group and UBS are included in this Analyst Blog.
Top Stock Reports for Analog Devices, Southern Company & Canadian Pacific Railway
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Analog Devices, Inc. (ADI), Southern Company (SO) and Canadian Pacific Railway Limited (CP).
CME (CME) Up 1.9% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
CME (CME) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's Why Holding CME Group (CME) Stock is a Prudent Move
by Zacks Equity Research
A compelling product portfolio, global presence, focus on over-the-counter clearing services and effective capital deployment poise CME Group (CME) for growth.
Zacks Industry Outlook Highlights Intercontinental Exchange, CME Group, Cboe, Global Markets, Nasdaq and MarketAxess Holdings
by Zacks Equity Research
Intercontinental Exchange, CME Group, Cboe, Global Markets, Nasdaq and MarketAxess Holdings are part of the Zacks Industry Outlook article.
5 Securities and Exchanges Stocks to Gain From Increased Trading
by Tanuka De
Product innovation, increased market volatility and a strategic economic market model are expected to aid Securities and Exchanges stocks like ICE, CME, CBOE, NDAQ and MKTX. However, compliance with regulations remains a challenge.
Here's Why Hold is an Apt Strategy for CME Group (CME) Stock
by Zacks Equity Research
A compelling product portfolio, global presence, focus on over-the-counter clearing services and effective capital deployment poise CME Group (CME) for growth.
The Zacks Analyst Blog Highlights Meta Platforms, Becton Dickinson, CME Group, Chipotle Mexican Grill and ParkerHannifin
by Zacks Equity Research
Meta Platforms, Becton Dickinson, CME Group, Chipotle Mexican Grill and ParkerHannifin are included in this Analyst Blog.
Top Analyst Reports for Meta Platforms, Becton Dickinson & CME Group
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Berkshire Meta Platforms, Inc. (META), Becton, Dickinson and Company (BDX) and CME Group (CME).
Cboe Global (CBOE) Q3 Earnings, Revenues Top, View Revised
by Zacks Equity Research
Cboe Global (CBOE) Q3 results reflect record net revenues and adjusted earnings, courtesy of a robust derivatives franchise, supported by sizable contributions from data and access solutions and cash and spot markets.
Intercontinental (ICE) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
Intercontinental (ICE) Q3 results reflect persistent revenue growth, driven by strong Exchanges and Fixed Income and Data Services. The results benefited from the strength of its technology and data services.
CME Group (CME) Q3 Earnings Beat on Higher Trading Volume
by Zacks Equity Research
CME Group (CME) Q3 results reflect higher revenues, driven by increased trading volume.
CME Group (CME) Q3 Earnings and Revenues Beat Estimates
by Zacks Equity Research
CME (CME) delivered earnings and revenue surprises of 2.59% and 0.14%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
CME Group (CME) to Report Q3 Earnings: What's in Store?
by Zacks Equity Research
CME Group's (CME) Q3 earnings are likely to have been aided by improved clearing, transaction fees and other revenues, and market data and information services. However, higher expenses might have been an offset.
Nasdaq (NDAQ) Beats on Q3 Earnings, Cuts Expense View
by Zacks Equity Research
Nasdaq (NDAQ) Q3 earnings reflect solid performance in both segments.
CME Group (CME) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
CME (CME) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Nasdaq (NDAQ) to Report Q3 Earnings: What's in the Offing?
by Zacks Equity Research
Solid organic revenue growth, strong performance at index and analytics businesses and contributions from the acquisition of Verafin are likely to have aided Nasdaq's third-quarter performance.
MarketAxess (MKTX) Gears Up for Q3 Earnings: What to Expect?
by Zacks Equity Research
MarketAxess' (MKTX) third-quarter results are likely to gain from increased total commissions.
Here's How Investors Can Find Strong Finance Stocks with the Zacks ESP Screener
by Zacks Equity Research
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Top Stock Reports for PepsiCo, Thermo Fisher Scientific & Canadian National Railway
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including PepsiCo, Inc. (PEP), Thermo Fisher Scientific Inc. (TMO) and Canadian National Railway Company (CNI).
The Zacks Analyst Blog Highlights Merck, Cisco, Morgan Stanley, CME Group and Canadian Natural Resources
by Zacks Equity Research
Merck, Cisco, Morgan Stanley, CME Group and Canadian Natural Resources are included in this Analyst Blog.
Top Analyst Reports for Merck, Cisco & Morgan Stanley
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Merck & Co., Inc. (MRK), Cisco Systems, Inc. (CSCO) and Morgan Stanley (MS).